Research Firm Asks FDA To Clear Path For Generic Fosamax
Research firm Clinipace Worldwide has recently asked the U.S. Food and Drug Administration in a citizen petition to issue a finding that Merck & Co. did not discontinue the drug Fosamax...To view the full article, register now.
Already a subscriber? Click here to view full article